Key result
Leadless pacemaker implantation resolves symptoms in pregnancy with minimal fluoroscopy time of ~2 minutes.
Why the study?
Bradyarrhythmias with syncope during pregnancy present complex challenges, requiring device implantation procedures that minimize fluoroscopy exposure for maternal and fetal safety.
Does leadless pacemaker implantation safely treat symptomatic sinus pauses and syncope in pregnant patients while minimizing radiation exposure?
Case Report (n=1)
Does leadless pacemaker implantation safely treat symptomatic sinus pauses and syncope in pregnant patients while minimizing radiation exposure?
Leadless pacemaker implantation is a feasible alternative to conventional pacing in pregnant women with severe bradyarrhythmia, offering a minimally invasive approach with minimal radiation exposure to ensure maternal and fetal safety.
Answers are grounded in this paper and cite their sources.
May offer low-radiation pacing option in pregnancy; leaves open need for prospective safety data.
Bradyarrhythmias with syncope during pregnancy present a complex and multifaceted challenge for both patients and health care providers. When device implantation is indicated for bradyarrhythmia-associated syncope during pregnancy, the procedure should be performed with particular attention to minimizing fluoroscopy exposure to ensure maternal and fetal safety. A 29-year-old woman at 15 weeks of gestation with sinus pauses presented with recurrent syncopal episodes. The patient underwent Micra™ AV leadless pacemaker implantation (Medtronic, Minneapolis, MN, USA) with a radiation exposure of 26.5 mGy and a total fluoroscopy time of 2 min, which is generally considered a negligible dose during pregnancy, based on the recommendations of the National Council on Radiation Protection and Measurements. In pregnant patients, a leadless pacemaker may offer a viable alternative to conventional pacing, primarily due to its reduced radiation exposure, shorter procedure time, minimally invasive approach, absence of transvenous leads, and lower risk of site infection.
No takes yet. Share an insight, caveat, or question.
Yokokawa et al. (2026) conducted a case report in Bradyarrhythmia with syncope during pregnancy (n=1). Micra AV leadless pacemaker implantation was evaluated. Micra AV leadless pacemaker implantation was successfully performed in a pregnant patient with minimal radiation exposure and fluoroscopy time (2 min), resulting in symptom resolution.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: